Increased susceptibility to cytomegalovirus infection in beige mutant mice
about
An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cellsLysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicityChemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in miceJinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosisEffects of the beige mutation on respiratory tract infection with Pseudomonas aeruginosa in miceLeishmaniasis in beige miceCytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host.Comparative genomics and host resistance against infectious diseasesNK cells and apoptosis.Cytomegalovirus, Macrophages and Breast Cancer.The pathogenicity of cytomegalovirus.Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic miceControlling cytomegalovirus: helping the immune system take the leadInnate immunity defines the capacity of antiviral T cells to limit persistent infectionDeciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infectionsModulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everythingCytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.Cytomegalovirus infection and cardiac allograft vasculopathy.Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance.Viral escape mechanisms--escapology taught by viruses.Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match.Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.Identification of Mouse Cytomegalovirus Resistance Loci by ENU Mutagenesis.Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation.Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis.Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex.Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK CellsThe effect of the beige mutation on infection with murine cytomegalovirus: histopathologic studies.Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes.Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen.Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infectionMechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H.Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice.
P2860
Q24310297-63B7B3A5-1CB3-4A73-93FC-B32AA5E04DCDQ27486907-6CFCA469-3630-4A3C-8A93-DF969391373DQ28320238-D4B66648-56EB-42D6-8E21-846394843AF3Q28506181-721F2FFF-19AB-4385-BBA2-9AAE7F1FF207Q28591043-ACEDD102-08E2-4A31-94F6-E4B982449CDAQ28593003-BEC9C865-462D-488E-9496-31CB325D710AQ30478992-2E6DDC08-F29E-4B6F-912A-4A730AF07DB2Q33542428-37BE3CED-FC55-4C29-AC42-2A0E3979E629Q33547794-5BD19DCB-884B-49E5-85C4-9C6BAB15E826Q33645055-E5F1CF59-7EE9-46A7-B1EA-939DFB35BCDCQ33697113-97671FB9-EADA-4FB0-BFA8-D9AA90A2AED9Q33782971-8F8748F2-22B0-4C74-AAA9-5732E1FC6E94Q33820695-34489B35-0DA8-4D05-804B-FD9072E03EF5Q33902354-8C617E4D-F7BF-4383-AEB6-4BD922F27B94Q33965560-3E59A72D-7B37-4C7B-94D7-D8CC6DC25C6BQ34022257-EF20D15F-AE23-4D74-BB57-74C564AF3172Q34169756-D88E44E6-444C-40D3-A135-AD0C21B2D685Q34294809-1B4719A0-2422-40E7-945A-DC78E5D09C87Q34357626-117FB184-F9F4-4AB3-9D3E-2CEB0328DD73Q34434767-6DD27961-A521-491D-AB28-FA2AD0C6190CQ34761230-D1B3D1EB-2FD2-4486-9CEE-0F815736AC55Q35126170-033ED106-2290-4450-A641-B7DAD836240EQ35155018-6FA7AD5B-FFD4-4769-924D-1FB41D06FE9FQ35259980-A0EB0E4B-38A8-4A18-A272-B3EE8E1231AFQ35559258-1956CDFA-76E0-490B-A761-0A085D41376DQ35763578-E9A4B5BB-A30F-4C70-9682-99C5FAFC7FECQ35797231-2DF1753B-187E-4418-B085-092E1A8668B4Q35833430-D96AA324-A93A-46FB-95BA-F59AA733C2F7Q35874845-6E8FE995-EAE5-42A2-AB7D-A89D33253E86Q35882584-0089E338-26EC-4DF8-88B5-185D0382752FQ35885048-5CB04299-58DF-4FEC-BE3A-AFBF6ECFFB76Q36328998-8EFC43B4-4BC3-43C2-8117-B09245FCE94AQ36351047-045AA838-7879-4367-919D-1273FC9337D2Q36365733-6208FD15-93B8-48E9-96AE-19D672136FF7Q36369341-E5D2B195-0A4E-47DA-AA12-00C76340726AQ36370222-B21DC06D-6B01-4583-A43F-A91234D752C2Q36548764-221E8A72-2579-4E9E-8C7D-997689D46F94Q36793382-F4E511C0-4733-4A93-93FC-A7E0857DA3CBQ36828793-0EBE88F9-E7D1-4F12-8B9C-F6E1594C5511Q36857476-942E135D-64A2-4979-85BD-EFB2A24C0AB7
P2860
Increased susceptibility to cytomegalovirus infection in beige mutant mice
description
1981 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1981
@ast
im August 1981 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1981/08/01)
@sk
vědecký článek publikovaný v roce 1981
@cs
wetenschappelijk artikel (gepubliceerd op 1981/08/01)
@nl
наукова стаття, опублікована в серпні 1981
@uk
name
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@ast
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@en
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@nl
type
label
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@ast
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@en
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@nl
prefLabel
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@ast
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@en
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@nl
P2093
P2860
P356
P1476
Increased susceptibility to cytomegalovirus infection in beige mutant mice
@en
P2093
G. J. Bancroft
G. R. Shellam
J. E. Allan
J. M. Papadimitriou
P2860
P304
P356
10.1073/PNAS.78.8.5104
P407
P577
1981-08-01T00:00:00Z